Pasanisi F, Contaldo F, de Simone G, Mancini M
Department of Clinical and Experimental Medicine, Federico II University, Naples, Italy.
Nutr Metab Cardiovasc Dis. 2001 Dec;11(6):401-6.
Over the last few years, weight loss has been recognised as a key factor in the control and prevention of coronary heart disease, hypertension, type 2 diabetes, hyperlipidaemia, cardiorespiratory failure and other chronic degenerative diseases. It has been shown that even a modest loss of 5% of initial body weight can reduce, eliminate or prevent these disorders in a large proportion of overweight patients. The early benefits of weight loss can be explained by the direct effects of a low calorie diet, but the long-term effects can only partially be attributed to diet, physical exercise or behavioural modifications. Long-term studies have shown that a sustained moderate weight loss of 10% improves glycemic control as a result of reduced insulin resistance, the better control or prevention of hypertension, increased HDL-and decreased LDL-cholesterol and VLDL triglycerides, improved diastolic function and the propagation of a cardiac stimulus that reduces the risk of ventricular arrhythmias. The health benefits of modest weight loss are particularly evident and useful when excess body fat is a major health hazard, as in the case of class III obesity (BMI > 40 kg/m2), which is often characterised by prevalent visceral fat accumulation. Baseline serum glucose, cholesterol, triglyceride, uric acid and blood pressure levels are usually higher in the upper body than is the case in peripheral obesity, and tend to decrease more in response to moderate weight loss. A therapeutic programme aimed at obtaining a gradual and moderate weight loss avoids the complications due to the rapid weight loss associated with inappropriate, unbalanced diets or even more harmful treatments. These complications include cholelithiasis and the subsequent risk of cholecystitis, lean body mass loss and a stable decrease in energy expenditure with a high probability of regaining weight (weight cycling syndrome). In conclusion, a large number of obese patients may be sensitive to a modest weight loss even without the achievement of ideal body weight. Sustained moderate weight loss by itself is definitely beneficial in obesity (especially "malignant" and "morbid" obesity), but also in diabetes, hypertension, hyperlipidaemia, cardiorespiratory diseases and other chronic degenerative diseases associated with any degree of excess body fat.
在过去几年中,体重减轻已被公认为是控制和预防冠心病、高血压、2型糖尿病、高脂血症、心肺功能衰竭及其他慢性退行性疾病的关键因素。研究表明,即使初始体重仅适度减轻5%,也能在很大比例的超重患者中减轻、消除或预防这些疾病。体重减轻的早期益处可通过低热量饮食的直接作用来解释,但长期效果只能部分归因于饮食、体育锻炼或行为改变。长期研究表明,持续适度减重10%可改善血糖控制,这是由于胰岛素抵抗降低、高血压得到更好控制或预防、高密度脂蛋白增加以及低密度脂蛋白胆固醇和极低密度脂蛋白甘油三酯降低、舒张功能改善以及心脏刺激传导改善,从而降低室性心律失常的风险。当身体脂肪过多成为主要健康危害时,如III级肥胖(体重指数>40kg/m²),通常以内脏脂肪普遍堆积为特征,适度体重减轻对健康的益处尤为明显且有用。上半身肥胖者的基线血清葡萄糖、胆固醇、甘油三酯、尿酸和血压水平通常高于外周肥胖者,并且在适度体重减轻后往往下降得更多。旨在实现逐渐适度体重减轻的治疗方案可避免因不适当、不均衡饮食或更有害治疗导致的快速体重减轻所引发的并发症。这些并发症包括胆石症及随后的胆囊炎风险、瘦体重减少以及能量消耗稳定下降,且体重很可能反弹(体重循环综合征)。总之,大量肥胖患者即使未达到理想体重,可能也对适度体重减轻敏感。持续适度体重减轻本身对肥胖(尤其是“恶性”和“病态”肥胖)肯定有益,对糖尿病、高血压、高脂血症、心肺疾病及其他与任何程度身体脂肪过多相关的慢性退行性疾病也有益。